Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-31 @ 3:47 AM
Study NCT ID:
NCT03450057
Status:
COMPLETED
Last Update Posted:
2024-03-29
First Post:
2018-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
Sponsor:
Hellenic Society of Hematology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EAE-2017/MM02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |